Sensitive ASX Announcement

FDA Extends New Drug Application Review Period for Illuccix

Published: 23/09/21, 08:39am (AEST)2 pages
Telix Pharmaceuticals Limited
TLX:ASXHealthcare

Recent TLX Announcements

Price Sensitive only